[HTML][HTML] Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities

R Amorim, P Soares, D Chavarria, S Benfeito… - European Journal of …, 2024 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) presents a pervasive global pandemic, affecting
approximately 25% of the world's population. This grave health issue not only demands …

Oxidative Stress as a Target for Non-Pharmacological Intervention in MAFLD: Could There Be a Role for EVOO?

A Seidita, A Cusimano, A Giuliano, M Meli, A Carroccio… - Antioxidants, 2024 - mdpi.com
Oxidative stress plays a central role in most chronic liver diseases and, in particular, in
metabolic dysfunction-associated fatty liver disease (MAFLD), the new definition of an old …

[HTML][HTML] Vitamin D Mitigates Hepatic Fat Accumulation and Inflammation and Increases SIRT1/AMPK Expression in AML-12 Hepatocytes

E Chang - Molecules, 2024 - mdpi.com
Emerging evidence has demonstrated a strong correlation between vitamin D status and
fatty liver disease. Aberrant hepatic fat infiltration contributes to oxidant overproduction …

Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease

YH Fan, S Zhang, Y Wang, H Wang, H Li… - Frontiers in …, 2025 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) is a multisystem metabolic disorder, marked by
abnormal lipid accumulation and intricate inter-organ interactions, which contribute to …

What Does Sarcopenia Have to Do with Nonalcoholic Fatty Liver Disease?

K Ferenc, S Jarmakiewicz-Czaja, R Filip - Life, 2023 - mdpi.com
Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver
disease. As the second stage of develo** steatosis, nonalcoholic hepatitis (NASH) carries …

[PDF][PDF] Evaluation of adropin level and insulin resistance in non-alcoholic fatty liver patients: a meta-analysis of studies.

F Alzoughool, R Abdelqader, S Abumweis… - European Review for …, 2024 - researchgate.net
OBJECTIVE: The recently discovered protein adropin is a highly conserved polypeptide that
plays critical functions in energy homeostasis, metabolic processes, fat metabolism, and …

[PDF][PDF] The relationship and diagnostic efficacy of N-terminal propeptide type III collagen in pathological changes associated with non-alcoholic steatohepatitis.

YJ Mi, Z Zhang, SL **, HM Yan… - European Review for …, 2024 - europeanreview.org
OBJECTIVE: This study delves into the role of N-terminal propeptide type III collagen
(PIIINP) in the diagnosis and management of liver pathological changes associated with non …